Cetuximab has not been studied in patients presenting with one or more of the following laboratory parameters: • haemoglobin < 9 g/ dl • leukocyte count < 3000/ mm³ • absolute neutrophil count < 1500/ mm³ • platelet count < 100000/ mm³